Krka dd Novo Mesto (KRKG.LJ) Key Developments | Reuters.com
Edition:
United States

Krka dd Novo Mesto (KRKG.LJ)

KRKG.LJ on Ljubljana Stock Exchange

58.00EUR
1 Jul 2016
Change (% chg)

-- (--)
Prev Close
€57.15
Open
€57.32
Day's High
€58.20
Day's Low
€57.25
Volume
7,173
Avg. Vol
--
52-wk High
--
52-wk Low
--

Latest Key Developments (Source: Significant Developments)

Krka dd Novo Mesto says dispute regarding esomeprazole in the Great Britain ended
Wednesday, 26 Aug 2015 06:03am EDT 

Krka dd Novo Mesto:AstraZeneca AB, Sweden and AstraZeneca UK Limited have not applied for leave to appeal at the Supreme Court against the decision of the Court of Appeal.Court of Appeal awarded to Krka damages and legal costs in the amount of slightly less than 21 million euros.damages and legal costs were for losses Krka had suffered because it was injuncted to sell its esomeprazole products in the Great Britain between mid-2010 to mid-2011 because alleged infringement of the patent EP 1 020 461.Krka will reverse the provisions formed for the esomeprazole case in the amount of 20 million euros as all legal means have been exhausted.reversal of provisions will be recognized in the 2015 financial statements.  Full Article